RTW Biotech Opportunities Ltd
RTWFF
$2.00
$0.073.63%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 34.57M | 34.84M | 35.11M | 21.65M | 8.19M |
| Total Revenue | 34.57M | 34.84M | 35.11M | 21.65M | 8.19M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 34.57M | 34.84M | 35.11M | 21.65M | 8.19M |
| SG&A Expenses | 12.15M | 12.22M | 12.30M | 11.80M | 11.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.69M | 13.58M | 13.48M | 12.82M | 12.16M |
| Operating Income | 20.88M | 21.26M | 21.63M | 8.83M | -3.97M |
| Income Before Tax | 245.19M | 76.41M | -92.38M | -29.10M | 34.18M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 245.19 | 76.41 | -92.38 | -29.10 | 34.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 245.19M | 76.41M | -92.38M | -29.10M | 34.18M |
| EBIT | 20.88M | 21.26M | 21.63M | 8.83M | -3.97M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.75 | 0.24 | -0.28 | -0.09 | 0.10 |
| Normalized Basic EPS | 0.15 | 0.07 | -0.02 | 0.03 | 0.08 |
| EPS Diluted | 0.75 | 0.24 | -0.28 | -0.09 | 0.10 |
| Normalized Diluted EPS | 0.15 | 0.07 | -0.02 | 0.03 | 0.08 |
| Average Basic Shares Outstanding | 1.31B | 1.32B | 1.33B | 1.34B | 1.34B |
| Average Diluted Shares Outstanding | 1.31B | 1.32B | 1.33B | 1.34B | 1.34B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |